Skip to content
healthcare.dev

Insulin Glargine-aldy

NDC 87682-080, insulin glargine-aldy, injection, solution, from Lanexa Biologics, LLC.

Product NDC
87682-080
Status
Listed
Labeler
Lanexa Biologics, LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761412
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87682-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
87682-080-05876820080055 SYRINGE in 1 CARTON (87682-080-05) / 3 mL in 1 SYRINGE (87682-080-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/536a4b0a-4b7c-2d23-e063-6294a90a7b7c

Use it

Look up 87682-080 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87682-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87682-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.